[
    [
        {
            "time": "",
            "original_text": "科伦药业创仿结合发力自主研发 药物制剂业务销售或超百亿",
            "features": {
                "keywords": [
                    "科伦药业",
                    "创仿结合",
                    "自主研发",
                    "药物制剂",
                    "销售"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "科伦药业创仿结合发力自主研发 药物制剂业务销售或超百亿",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "锦欣生殖上市遇冷 “不孕不育”蓝海变局隐现",
            "features": {
                "keywords": [
                    "锦欣生殖",
                    "上市遇冷",
                    "不孕不育",
                    "蓝海变局"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "锦欣生殖上市遇冷 “不孕不育”蓝海变局隐现",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "复星医药：药品研发多点开花，业绩有望逐季加速",
            "features": {
                "keywords": [
                    "复星医药",
                    "药品研发",
                    "多点开花",
                    "业绩",
                    "逐季加速"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：药品研发多点开花，业绩有望逐季加速",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-07-11",
            "original_text": "【信达看盘】2019.7.11",
            "features": {
                "keywords": [
                    "信达看盘",
                    "2019.7.11"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【信达看盘】2019.7.11",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 2,
                "Headline_Structure": 5,
                "Source_Recency": 1
            }
        },
        {
            "time": "",
            "original_text": "融资客青睐23股，华孚时尚买入占比高达65.30%",
            "features": {
                "keywords": [
                    "融资客",
                    "青睐",
                    "华孚时尚",
                    "买入占比",
                    "65.30%"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "纺织服装"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "融资客青睐23股，华孚时尚买入占比高达65.30%",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]